ReviewFrontiers in immunology2026
From inflammatory activation to fibrotic remodeling: the central role of macrophage heterogeneity in frozen shoulder.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Immune Cell Causality and Glucocorticoid Trade-Off in Frozen Shoulder: Integrative MR-RNA-Seq Analysis.Biomedicines · 2026Article
- Chronic Sleep Disturbance Enhances Inflammation and Collagen Production in Neural- and Myofascial Tissues in Uninjured Rats.International journal of molecular sciences · 2026Article
- Advanced Functional Wound Dressings in Precision Surgery: Immunometabolic Reprogramming, Bioadaptive Biomaterials, and Intelligent Regenerative Interfaces.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Frozen shoulder (FS) is a condition primarily marked by chronic inflammation and progressive fibrosis of the glenohumeral capsule. Clinically, it presents with persistent shoulder pain and limited joint mobility, often leading to impaired upper limb function and reduced quality of life. In recent years, research on the molecular mechanisms of fibrosis in FS has deepened; however, there remains a lack of systematic focus on the dynamic regulation of the immune microenvironment, particularly the role of macrophage heterogeneity. The remarkable functional plasticity of macrophages allows them to play dual roles in inflammatory responses and tissue repair, with the sequential transformation of their phenotypes and functions potentially governing various stages of FS development. This review focuses on the dynamic evolution of macrophage function and polarization states during FS progression. This review systematically outlines the key roles of these cells in inflammatory responses, fibrosis progression, and their signaling interactions with fibroblasts. We systematically assessed the critical signaling networks that regulate macrophage recruitment and differentiation, emphasizing the core roles of the C-C motif chemokine ligand 2 (CCL2)/C-C chemokine receptor type 2 (CCR2) chemotactic axis and tissue mechanical signals in this process. Additionally, we explored how the synergy between immune signaling and mechanotransduction maintains the pathogenic activation state of macrophages, potentially forming a positive feedback loop for fibrosis. Targeting these upstream inputs holds promise as a potential intervention to disrupt the link between inflammation and fibrosis. A deeper understanding of the regulatory mechanisms governing macrophage heterogeneity will lay the foundation for developing more targeted therapeutic approaches for FS in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.